Regulation of Protein Degradation by Insulin-degrading Enzyme: Analysis by Small Interfering RNA-mediated Gene Silencing
Overview
Biophysics
Affiliations
Proteins are vital to the overall structure of cells and to the function of cells in the form of enzymes. Thus the control of protein metabolism is among the most important aspects of cellular metabolism. Insulin's major effect on protein metabolism in the adult animal is inhibition of protein degradation. This is via inhibition of proteasome activity via an interaction with insulin-degrading enzyme (IDE). IDE is responsible for the majority of cellular insulin degradation. We hypothesized that a reduction in IDE would reduce insulin degradation and insulin's ability to inhibit protein degradation. HepG2 cells were transfected with siRNA against human IDE and insulin degradation and protein degradation measured. Both IDE mRNA and protein were reduced by >50% in the IDE siRNA transfected cells. Insulin degradation was reduced by approximately 50%. Cells were labeled with [3H]-leucine to investigate protein degradation. Short-lived protein degradation was unchanged in the cells with reduced IDE expression. Long-lived and very-long-lived protein degradation was reduced in the cells with reduced IDE expression (14.0+/-0.16 vs. 12.5+/-0.07%/4h (long-lived), 9.6+/-2.2% vs. 7.3+/-0.2%/3h (very-long-lived), control vs. IDE transfected, respectively, P<0.005). The inhibition of protein degradation by insulin was reduced 37-76% by a decreased expression of IDE in HepG2 cells. This shows that IDE is involved in cellular insulin metabolism and provides further evidence that insulin inhibits protein degradation via an interaction with IDE.
New Insights on the Regulation of the Insulin-Degrading Enzyme: Role of microRNAs and RBPs.
Martin-Martin Y, Perez-Garcia A, Torrecilla-Parra M, Frutos M, Pardo-Marques V, Casarejos M Cells. 2022; 11(16).
PMID: 36010613 PMC: 9406717. DOI: 10.3390/cells11162538.
Insulin-Degrading Enzyme, an Under-Estimated Potential Target to Treat Cancer?.
Lesire L, Leroux F, Deprez-Poulain R, Deprez B Cells. 2022; 11(7).
PMID: 35406791 PMC: 8998118. DOI: 10.3390/cells11071228.
Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme.
Gonzalez-Casimiro C, Merino B, Casanueva-Alvarez E, Postigo-Casado T, Camara-Torres P, Fernandez-Diaz C Biomedicines. 2021; 9(1).
PMID: 33477364 PMC: 7830943. DOI: 10.3390/biomedicines9010086.
Modulation of insulin degrading enzyme activity and liver cell proliferation.
Pivovarova O, von Loeffelholz C, Ilkavets I, Sticht C, Zhuk S, Murahovschi V Cell Cycle. 2015; 14(14):2293-300.
PMID: 25945652 PMC: 4613656. DOI: 10.1080/15384101.2015.1046647.
Charton J, Gauriot M, Guo Q, Hennuyer N, Marechal X, Dumont J Eur J Med Chem. 2014; 79:184-93.
PMID: 24735644 PMC: 4128174. DOI: 10.1016/j.ejmech.2014.04.009.